Screening for cancer: lessons learned from the prostate, lung, colorectal, and ovarian cancer screening trial.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 25959167.
- Also identified by DOI 10.1016/j.eururo.2015.04.026.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
While the PLCO Cancer Screening trial demonstrated no observed mortality benefit associated with screening for prostate cancer with prostate-specific antigen and rectal exam, the knowledge gained about prostate cancer and screening and resources developed in completing the trial make the trial a success.
Medical subject headings
- Colorectal Neoplasms
- Early Detection of Cancer
- Lung Neoplasms
- Ovarian Neoplasms
- Prostatic Neoplasms